Vaxxas Investors

20 investors on Angel Roster list Vaxxas in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in Australia and the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Vaxxas can appear together.

Investors listed
20
With verified email
55%
Most common stage
Seed
Top location
Australia

Updated October 13, 2026 · How we compile this data

Top 20 Vaxxas investors

The most complete profiles first. Showing 20 of 20.

  • Ingmar WahlqvistVerified

    Venture Capital, Investor · Australia

    SeedHealth CareLife ScienceEducationBiotechnology

    Portfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more

    Verified email available

  • Mara MacdonaldVerified

    Venture Capital, Private Equity Firm, Investor · Australia

    SeedHealth CareLife ScienceEducationBiotechnology

    Portfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more

    Verified email available

  • Melissa ByrneVerified

    Venture Capital, Investor · Australia

    SeedHealth CareLife ScienceEducationBiotechnology

    Portfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more

    Verified email available

  • Michael BettessVerified

    Venture Capital, Private Equity Firm, Investor · Australia

    SeedHealth CareLife ScienceBiotechnologyHealth and Hospital Services

    Portfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more

    Verified email available

  • Aaron TanVerified

    Venture Capital · Australia

    Health CareAutonomous VehiclesE-commerceWomen Founded

    Portfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more

    Verified email available

  • Darren KellyVerified

    Venture Capital · Australia

    Health CareLife ScienceBiotechnologyNeuroscience

    Portfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more

    Verified email available

  • David FisherVerified

    Venture Capital, Private Equity Firm · Australia

    Health CareLife ScienceBiotechnologyNeuroscience

    Portfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more

    Verified email available

  • Douglas OnsiVerified

    Angel/Individual · United States

    Health CareSportsEducationInformation Technology (IT)

    Portfolio: Togga, Tensha Therapeutics, Zymergen, Pragya Systems and 7 more

    Verified email available

  • James CavanaughVerified

    Venture Capital · United States

    Health CareWearablesGeneticsE-commerce

    Portfolio: Apofore, Catalyst Biosciences, Avidia, Proteostasis Therapeutics and 52 more

    Verified email available

  • Paul KellyVerified

    Venture Capital, Private Equity Firm · Australia

    Health CareAutonomous VehiclesE-commerceWomen Founded

    Portfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more

    Verified email available

  • Stephen ThompsonVerified

    Venture Capital · Australia

    Health CareLife ScienceBiotechnologyNeuroscience

    Portfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more

    Verified email available

  • Melissa McBurnie

    Venture Capital, Private Equity Firm, Investor · Australia

    SeedHealth CareLife ScienceBiotechnologyHealth and Hospital Services

    Portfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more

    Contact details available

  • Anne

    Venture Capital, Private Equity Firm · Australia

    Health CareAutonomous VehiclesE-commerceWomen Founded

    Portfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more

    Contact details available

  • Gabriel Douville

    Venture Capital · Australia

    Health CareAutonomous VehiclesE-commerceWomen Founded

    Portfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more

    Contact details available

  • Kate Madden

    Venture Capital, Private Equity Firm · Australia

    Health CareAutonomous VehiclesE-commerceWomen Founded

    Portfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more

    Contact details available

  • Kerensa Argyriou

    Venture Capital · Australia

    Health CareLife ScienceBiotechnologyNeuroscience

    Portfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more

    Contact details available

  • Leighton Read

    Venture Capital, Private Equity Firm · United States

    Health CareLife ScienceBiotechnologyNeuroscience

    Portfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more

    Contact details available

  • Michelle Deaker

    Venture Capital, Private Equity Firm · Australia

    Health CareAutonomous VehiclesE-commerceWomen Founded

    Portfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more

    Contact details available

  • Nick Gainsley

    Venture Capital, Private Equity Firm · Australia

    Health CareAutonomous VehiclesE-commerceWomen Founded

    Portfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more

    Contact details available

  • Sarah Meibusch

    Venture Capital, Private Equity Firm · Australia

    Health CareAutonomous VehiclesE-commerceWomen Founded

    Portfolio: AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies and 20 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

  • Q-Sera10
  • MetaBloQ10
  • Heart Metabolics10
  • QUE Oncology10
  • Spinifex Pharmaceuticals10
  • Solvanix10
  • MecRx10
  • Fibrotech Therapeutics10
  • Okogen10
  • Cardiora10
  • Auspherix10

Frequently asked questions

How many Vaxxas investors are on Angel Roster?

Angel Roster lists 20 Vaxxas investors. 11 of them (55%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (19), Private Equity Firms (11) and Angel Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Vaxxas investors invest in?

Among those that list a stage, the most common are Seed (5).

Where are Vaxxas investors based?

Most are based in Australia (17) and the United States (3).

Which companies have Vaxxas investors backed?

The most-backed portfolio companies among them are Q-Sera (10), MetaBloQ (10), Heart Metabolics (10), QUE Oncology (10) and Spinifex Pharmaceuticals (10).

How do I contact Vaxxas investors?

Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.